Koios Medical
About Koios Medical
Koios Medical is a healthcare AI company that develops advanced software solutions for radiologists, primarily focused on enhancing diagnostic accuracy and workflow efficiency in cancer detection through ultrasound imaging. Their flagship products, Koios DS Breast and Koios DS Thyroid, also known as Smart Ultrasound™, utilize proprietary artificial intelligence and deep machine learning algorithms. These algorithms have been trained on extensive datasets, including over 500,000 ultrasound images of breast lesions linked to pathology results, and a broader dataset exceeding 2 million ultrasound images for their Smart Ultrasound™ platform.
For physicians, Koios Medical’s technology acts as an intelligent, on-demand second opinion, providing real-time, evidence-based clinical decision support. This support aims to improve diagnostic confidence, speed up clinical decisions, and significantly reduce the rate of unnecessary biopsies (by up to 20% fewer benign biopsies) while simultaneously increasing the detection rate of cancers (by up to 5% more cancers caught). The software is FDA-cleared and CE Mark approved, ensuring regulatory compliance and clinical utility. It can be seamlessly integrated into existing Picture Archiving and Communication Systems (PACS) or deployed directly on ultrasound scanners, thereby streamlining reporting and overall workflow. The company is also actively expanding its deep learning platform to address other disease areas, including lung, prostate, and skin cancer, underscoring its commitment to transforming diagnostics across multiple medical specialties.
Focus Areas
Business Intelligence
| Key Investors | Mitsui & Co. (MBK Healthcare Management), Daiwa JPI Alternative Investments, New Age Ventures, Bold Brain Capital, National Cancer Institute, National Institute of Biomedical Imaging and Bioengineering, BITKRAFT Ventures, Brighter Capital, Electric Capital, Ethereal Ventures, Hartmann Capital, Mercury Fund, MetaProp Ventures, Polygon, Third Prime, Jutta Steiner, Matias Woloski, Maya Zehavi, Scott Belsky, Teck Chia |
| Partnerships | GE Healthcare, Philips, RamSoft, iCAD, Sirona Medical |
| Technology | AI algorithms, machine learning, deep learning, computer vision, ensemble of algorithms, proprietary dataset (over 2 million ultrasound images), vendor-agnostic, PACS integration |
| FDA Clearances | 4 cleared products (estimated) |
What Physicians Need to Know
Koios Medical's 'SmartUltrasound' platform offers physicians an 'expert on-demand second opinion' to enhance diagnostic accuracy and confidence, especially in challenging cases. It significantly reduces interpretation time and automates reporting, freeing up valuable clinical time and combating physician burnout. The technology is proven to reduce unnecessary biopsies for breast lesions (up to 31%) and helps avoid unwarranted fine needle aspirations for thyroid nodules, leading to better patient outcomes and reduced healthcare costs. Furthermore, its alignment with established reporting guidelines like BI-RADS, TI-RADS, and ATA ensures standardized and consistent assessments. The availability of CPT Category 3 codes makes the use of Koios DS a billable procedure.
Koios DS software is designed for seamless integration into most PACS workstations, supporting DICOM protocols for smooth communication within existing radiology workflows. It can be deployed on-site as an ASP.NET web application on an IIS Web Server with a Windows operating system and SQL Server. The software is also integrated into specific ultrasound systems, such as GE Healthcare's LOGIQu2122 E10. Strategic partnerships, like those with iCAD and RamSoft, expand its reach by offering comprehensive, multi-modality AI suites for breast cancer detection and integrated cloud-based RIS/PACS solutions. Koios DS is compatible with major ultrasound hardware manufacturers, ensuring broad applicability.
What the Web Says
Koios Medical develops AI-powered software, Koios DS, for clinical decision support in diagnosing breast and thyroid cancer using ultrasound. The software has received FDA clearance and is designed to improve diagnostic accuracy, reduce unnecessary biopsies, and streamline radiologist workflows. While there is extensive information on their product's efficacy and features, public reviews specifically from G2, Glassdoor, Capterra, or Reddit regarding employer experiences or direct product user opinions are limited or not readily available.
Overall: PositiveStrengths
- Improved accuracy in breast and thyroid cancer diagnosis
- Reduced unnecessary benign breast biopsies (by up to 37-70%)
- Increased thyroid cancer detection rates (up to 14%)
- Decreased interpretation variability among physicians (over 50%)
- Streamlined workflow and reduced time spent per case (by up to 24%)
- FDA-cleared and CE Marked, with alignment to ACR BI-RADS and TI-RADS systems
Limitations
- Limited public employee or product user reviews on major platforms (G2, Glassdoor, Capterra, Reddit)
- No readily available information on potential drawbacks or challenges from user perspectives
Based on reviews from: Elion, Fierce Biotech, Applied Radiology, Koios Medical Official Website, FirstWord HealthTech, TestDynamics
Last updated: 2026-07-18
Videos
News, demos, and interviews about Koios Medical.
Videos load interactively. If none appear, search YouTube for Koios Medical →
Press & Coverage
Frequently Asked Questions
Comparisons
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]